Patient-Reported Outcomes with Once Weekly Dulaglutide vs. Insulin Glargine (AWARD-2). Abstract. Poster presented at the 74th Scientific Sessions of the American Diabetes Association - Reaney, M; Yu, M; vanBrunt, K
13–17 June 2014, 979-P.